Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Computationally Optimized SARS-CoV-2 MHC Class I and II Vaccine Formulations Predicted to Target Human Haplotype Distributions
Ge Liu, Brandon Carter, Trenton Bricken, et al.
Cell Systems (2020) Vol. 11, Iss. 2, pp. 131-144.e6
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Leveraging artificial intelligence in vaccine development: A narrative review
David B. Olawade, Jennifer Teke, Oluwaseun Fapohunda, et al.
Journal of Microbiological Methods (2024) Vol. 224, pp. 106998-106998
Open Access | Times Cited: 17
Developing T Cell Epitope-Based Vaccines Against Infection: Challenging but Worthwhile
Xian Tang, Wei Zhang, Zheng Zhang
Vaccines (2025) Vol. 13, Iss. 2, pp. 135-135
Open Access | Times Cited: 1
Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19
Gunjan Arora, Jayadev Joshi, Rahul Shubhra Mandal, et al.
Pathogens (2021) Vol. 10, Iss. 8, pp. 1048-1048
Open Access | Times Cited: 73
In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives
Muhammad S. Sohail, Syed Faraz Ahmed, Ahmed Abdul Quadeer, et al.
Advanced Drug Delivery Reviews (2021) Vol. 171, pp. 29-47
Open Access | Times Cited: 70
Machine learning research towards combating COVID-19: Virus detection, spread prevention, and medical assistance
Osama Shahid, Mohammad Nasajpour, Seyedamin Pouriyeh, et al.
Journal of Biomedical Informatics (2021) Vol. 117, pp. 103751-103751
Open Access | Times Cited: 66
Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2
Tahsin Khan, Md. Jahirul Islam, Arpana Parihar, et al.
Informatics in Medicine Unlocked (2021) Vol. 24, pp. 100578-100578
Open Access | Times Cited: 56
Virus–Host Interactions in Foot-and-Mouth Disease Virus Infection
Kangli Li, Congcong Wang, Fan Yang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 55
Artificial Intelligence and Internet of Things (AI-IoT) Technologies in Response to COVID-19 Pandemic: A Systematic Review
Junaid Iqbal Khan, Jebran Khan, Furqan Ali, et al.
IEEE Access (2022) Vol. 10, pp. 62613-62660
Open Access | Times Cited: 53
Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development
Nicholas Magazine, Tianyi Zhang, Anang D. Bungwon, et al.
ImmunoHorizons (2024) Vol. 8, Iss. 3, pp. 214-226
Open Access | Times Cited: 10
Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2?
Stanislav R. Kurpe, Sergei Y. Grishin, Alexey K. Surin, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9552-9552
Open Access | Times Cited: 54
Epitope prediction and identification- adaptive T cell responses in humans
John Sidney, Bjoern Peters, Alessandro Sette
Seminars in Immunology (2020) Vol. 50, pp. 101418-101418
Open Access | Times Cited: 50
Landscape and selection of vaccine epitopes in SARS-CoV-2
Christof C. Smith, Kelly Olsen, Kaylee M. Gentry, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 48
Revolutionizing Vaccine Development for COVID-19: A Review of AI-Based Approaches
Aritra Ghosh, María M. Larrondo-Petrie, Mirjana Pavlović
Information (2023) Vol. 14, Iss. 12, pp. 665-665
Open Access | Times Cited: 17
Graph-pMHC: graph neural network approach to MHC class II peptide presentation and antibody immunogenicity
William John Thrift, Jason Perera, Sivan Cohen, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 3
Open Access | Times Cited: 5
Predicted Cellular Immunity Population Coverage Gaps for SARS-CoV-2 Subunit Vaccines and Their Augmentation by Compact Peptide Sets
Ge Liu, Brandon Carter, David K. Gifford
Cell Systems (2020) Vol. 12, Iss. 1, pp. 102-107.e4
Open Access | Times Cited: 48
Current and prospective computational approaches and challenges for developing COVID-19 vaccines
Woochang Hwang, Winnie Lei, Nicholas M. Katritsis, et al.
Advanced Drug Delivery Reviews (2021) Vol. 172, pp. 249-274
Open Access | Times Cited: 39
The mutational landscape of SARS-CoV-2 variants diversifies T cell targets in an HLA-supertype-dependent manner
David Hamelin, Dominique Fournelle, Jean‐Christophe Grenier, et al.
Cell Systems (2021) Vol. 13, Iss. 2, pp. 143-157.e3
Open Access | Times Cited: 36
Methodological approach to identify immunogenic epitopes candidates for vaccines against emerging pathogens tailored to defined HLA populations
Nicolás Lalinde-Ruiz, Laura Camila Martínez-Enriquez, Dante Palacios Gutiérrez, et al.
Computational Biology and Chemistry (2025) Vol. 116, pp. 108389-108389
Open Access
A high-throughput yeast display approach to profile pathogen proteomes for MHC-II binding
Brooke D. Huisman, Zheng Dai, David K. Gifford, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 18
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
Brandon Carter, Pinghan Huang, Ge Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Computational Methods for Predicting Key Interactions in T Cell–Mediated Adaptive Immunity
Ryan Ehrlich, Eric Glynn, Mona Singh, et al.
Annual Review of Biomedical Data Science (2024) Vol. 7, Iss. 1, pp. 295-316
Closed Access | Times Cited: 2
Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions
Kuei-Ching Hsiung, Huan-Jung Chiang, Sebastian Reinig, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1345-1345
Open Access | Times Cited: 2
Artificial Intelligence for Vaccine Design
Peter McCaffrey
Methods in molecular biology (2021), pp. 3-13
Closed Access | Times Cited: 14
Leveraging Immunopeptidomics To Study and Combat Infectious Disease
Owen Leddy, Forest M. White, Bryan D. Bryson
mSystems (2021) Vol. 6, Iss. 4
Open Access | Times Cited: 13
Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine
Jane Qin, Ju Hyeong Jeon, Jiangsheng Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top